Mieke Van Bockstal - Concepedia

Author

Mieke Van Bockstal

Also Known As

M R Van Bockstal, M Van Bockstal, M. Van Bockstal, M.R van Bockstal, M.R. Van Bockstal, Michail Ignatiadis, Michiel de Maaker, Mieke R Van Bockstal, Mieke R. Van Bockstal, Mieke R. van Bockstal

163

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

Ghent University Hospital Cliniques Universitaires Saint-Luc KU Leuven Cancer Research Institute Ghent Ghent University

About

Mieke Van Bockstal is an author at Ghent University Hospital specializing in medicine, oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	27	1K
2	Health Sciences	6	6	305
3	Engineering	1	1	148
4	Natural Sciences	1	1	17
5	Public Health	1	1	25

Mieke Van Bockstal

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Genipin-crosslinked gelatin microspheres as a strategy to prevent postsurgical peritoneal adhesions: In vitro and in vivo characterization Kaat De Clercq, Charlotte Schelfhout, Marc Bracke, Biomaterials Tissue EngineeringEngineeringCell AdhesionCytoskeletonSurgery	2016	148
Cancer-Associated Adipose Tissue Promotes Breast Cancer Progression by Paracrine Oncostatin M and Jak/STAT3 Signaling Lore Lapeire, An Hendrix, Kathleen Lambein, Cancer Research Breast OncologyMolecular BiologyCancer BiologyTumor BiologySignaling Pathway	2014	139
Co-delivery of nucleoside-modified mRNA and TLR agonists for cancer immunotherapy: Restoring the immunogenicity of immunosilent mRNA Rein Verbeke, Ine Lentacker, Laura Wayteck, Journal of Controlled Release MedicineImmunologyNucleoside-modified MrnaTlr AgonistsTherapeutic Vaccine	2017	125
Differential secretome analysis of cancer‐associated fibroblasts and bone marrow‐derived precursors to identify microenvironmental regulators of colon cancer progression Astrid De Boeck, An Hendrix, Dawn Maynard, PROTEOMICS	2012	101
Distinguishing Score 0 From Score 1+ in HER2 Immunohistochemistry-Negative Breast Cancer Kathleen Lambein, Mieke Van Bockstal, Lies Vandemaele, American Journal of Clinical Pathology	2013	93
APOBEC3G Expression Correlates with T-Cell Infiltration and Improved Clinical Outcomes in High-grade Serous Ovarian Carcinoma Brandon Leonard, Gabriel J. Starrett, Matthew J. Maurer, Clinical Cancer Research	2016	85
The Impact of the COVID-19 Pandemic and the Associated Belgian Governmental Measures on Cancer Screening, Surgical Pathology and Cytopathology Marie-Caroline de Pelsemaeker, Yves Guiot, Jonathan Vanderveken, Pathobiology	2020	73
Tumor grafts derived from sarcoma patients retain tumor morphology, viability, and invasion potential and indicate disease outcomes in the chick chorioallantoic membrane model Gwen Sys, Mieke Van Bockstal, Ramses Forsyth, Cancer Letters Regenerative MedicineSurgical OncologyTumoral PathologySurgical PathologyPathology	2012	56
Interobserver variability in the assessment of stromal tumor-infiltrating lymphocytes (sTILs) in triple-negative invasive breast carcinoma influences the association with pathological complete response: the IVITA study Mieke Van Bockstal, Aline François, Serdar Altınay, Modern Pathology Breast OncologyCancer ImmunosurveillanceIvita StudyMedicineImmunology	2021	56
Inter‐observer agreement for the histological diagnosis of invasive lobular breast carcinoma Matthias Christgen, Leonie Donata Kandt, Wiebke Antonopoulos, The Journal of Pathology Clinical Research Breast OncologyTrabecular IlcDiagnosisPathologyGynecology	2021	48

Page 1